rilzabrutinib
sanofi
['rilzabrutinib']
#ash22 | hall d | sunday 6pm cst
clinical predictors of response to rilzabrutinib therapy in patients with immune thrombocytopenia: exploratory analysis of a phase 1/2 study
david kuter, md, dphil 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.